[EN] C-TERMINAL HSP90 INHIBITORS TO TREAT PITUITARY ADENOMAS<br/>[FR] INHIBITEURS DE HSP90 DE LIAISON AU DOMAINE C-TERMINAL POUR LE TRAITEMENT D'ADÉNOMES PITUITAIRES
申请人:MAX PLANCK GES ZUR FÖRDERUNG DER WISSENSCHAFT E V
公开号:WO2014106623A1
公开(公告)日:2014-07-10
The present invention relates to C-terminal HSP90 inhibitors, like silibinin, novobiocin and derivatives thereof, stereoisomeric forms, prodrugs, solvates, hydrates and/or pharmaceutically acceptable salts of these compounds as well as pharmaceutical compositions containing at least one of these compounds together with pharmaceutically acceptable carrier, excipient and/or diluents. Said compounds and its compositions have been identified as useful for the treatment of pituitary adenomas such as corticotroph adenomas, lactotroph adenomas, somatotroph adenomas and thyrotroph adenomas.